| USD millions | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 12.8 | 13.1 | 11.0 | 11.6 | 12.8 | 14.9 | +16.7% | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Gross profit | 12.8 | 13.1 | 11.0 | 11.6 | 12.8 | 14.9 | +16.7% | |
| Research & development | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Selling, general & administrative | 2.5 | 2.5 | 2.4 | 2.5 | 2.0 | 2.0 | +1.4% | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Operating expenses | 28.7 | 14.4 | 1.9 | 16.2 | 50.4 | 2.1 | −95.9% | |
| Operating income | 10.3 | 10.6 | 8.5 | 9.1 | 10.8 | 12.9 | +19.5% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other income / expense | (26.3) | 16.9 | 0.6 | (13.7) | (48.4) | 4.1 | +108.5% | |
| Pre-tax income | (15.9) | 27.5 | 9.1 | (4.6) | (37.6) | 17.0 | +145.2% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (15.9) | 27.5 | 9.1 | (4.6) | (37.6) | 17.0 | +145.2% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| EPS, basic (per share) | (0.78) | 1.35 | 0.45 | (0.23) | (1.84) | 0.84 | +145.7% | |
| EPS, diluted (per share) | (0.78) | 1.35 | 0.45 | (0.23) | (1.84) | 0.84 | +145.7% | |
| EBITDA | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.1 | — | |
| Depreciation & amortization | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | — | |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | +0.0 pts | |
| Operating margin | 80.6% | 81.1% | 77.7% | 78.7% | 84.3% | 86.4% | +2.0 pts | |
| Net margin | −124.4% | 209.8% | 83.0% | −39.9% | −293.9% | 113.9% | +407.8 pts |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
